Related Experiment Video
Updated: Feb 18, 2026

Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
Structure and immunogenicity of pre-fusion-stabilized human metapneumovirus F glycoprotein
Michael B Battles1, Vicente Más2, Eduardo Olmedillas2
1Department of Biochemistry and Cell Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, 03755, USA.
Abstract:
Human metapneumovirus (hMPV) is a frequent cause of bronchiolitis in young children. Its F glycoprotein mediates virus-cell membrane fusion and is the primary target of neutralizing antibodies. The inability to produce recombinant hMPV F glycoprotein in the metastable pre-fusion conformation has hindered structural and immunological studies. Here, we engineer a pre-fusion-stabilized hMPV F ectodomain and determine its crystal structure to 2.6 Å resolution. This structure reveals molecular determinants of strain-dependent acid-induced fusion, as well as insights into refolding from pre- to post-fusion conformations. A dense glycan shield at the apex of pre-fusion hMPV F suggests that antibodies against this site may not be elicited by host immune responses, which is confirmed by depletion studies of human immunoglobulins and by mouse immunizations. This is a major difference with pre-fusion F from human respiratory syncytial virus (hRSV), and collectively our results should facilitate development of effective hMPV vaccine candidates.
Insights
Researchers stabilized the human metapneumovirus (hMPV) F glycoprotein in its pre-fusion form, revealing its structure. This breakthrough aids in developing effective hMPV vaccines by understanding viral fusion mechanisms.
Area of Science:
- Virology
- Structural Biology
- Immunology
Background:
- Human metapneumovirus (hMPV) causes significant respiratory illness in children.
- The hMPV F glycoprotein is crucial for viral entry and a key target for neutralizing antibodies.
- Previous studies were limited by the inability to obtain the F glycoprotein in its pre-fusion conformation.
Purpose of the Study:
- To engineer and determine the crystal structure of a pre-fusion-stabilized hMPV F ectodomain.
- To elucidate the molecular mechanisms of hMPV fusion and antibody interactions.
Main Methods:
- Engineering a stabilized hMPV F ectodomain.
- X-ray crystallography to determine the structure at 2.6 Å resolution.
- Immunological studies including immunoglobulin depletion and mouse immunizations.
Main Results:
- The crystal structure of the pre-fusion hMPV F ectodomain was determined.
- Identified molecular determinants of strain-dependent, acid-induced fusion.
- Revealed insights into the conformational changes from pre- to post-fusion states.
- A dense glycan shield at the apex of pre-fusion hMPV F was observed, potentially hindering antibody recognition.
Conclusions:
- The structural insights provide a foundation for understanding hMPV entry mechanisms.
- The dense glycan shield differs from related viruses like hRSV, impacting vaccine design.
- These findings are critical for the rational development of novel hMPV vaccine candidates.
More Related Videos
07:53A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation
Published on: January 9, 2019
05:15Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
Published on: February 10, 2022
Related Concept Videos
Viral Structure
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...